timolol has been researched along with tafluprost in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 23 (74.19) | 24.3611 |
| 2020's | 8 (25.81) | 2.80 |
| Authors | Studies |
|---|---|
| Baranak, C; Chabi, A; Ho, TW; Lines, C; Lupinacci, R; Noble, L; Pigeon, J; Tsai, JC; Varma, R | 1 |
| Campagna, O; Colica, C; Cruciani, F; De Vico, U; Gharbiya, M | 1 |
| Antón López, A; Holló, G; Hommer, A; Ropo, A | 1 |
| Lorenz, K; Pfeiffer, N | 1 |
| Bautista, D; Chew, PT; Khoo, AL; Lim, BP; Lin, L; Sng, CC; Teng, M; Wong, HT; Wu, TS; Yip, LW; Zhao, YJ | 1 |
| Holló, G; Huttunen, T; Pfeiffer, N; Ropo, A; Tuominen, J; Vuorinen, J | 1 |
| Holló, G; Ropo, A | 1 |
| Astakhov, Y; Boiko, E; Liinamaa, J; Lorenz, K; Pfeiffer, N; Ropo, A; Saarela, V; Traverso, CE; Uusitalo, H | 1 |
| Holló, G; Katsanos, A | 1 |
| Akaishi, T; Kawazu, K; Miyawaki, N; Shimazaki, A; Tonouchi, A; Ueda, K | 1 |
| Ikäheimo, K; Kaarniranta, K; Mannermaa, E; Ropo, A | 1 |
| Hoy, SM | 1 |
| Ha, SJ; Seo, du R | 1 |
| Holló, G; Konstas, AG | 1 |
| Baranak, C; Chabi, A; Herring, WJ; Lupinacci, R | 1 |
| Akaishi, T; Fuwa, M; Kawazu, K; Kirihara, T; Mano, H; Shimazaki, A; Ueda, K; Yamashita, N | 1 |
| Boboridis, KG; Haidich, AB; Kapis, P; Katsanos, A; Konstas, AG; Marinopoulos, K; Mikropoulos, DG; Pagkalidou, E; Panayiotou, D; Quaranta, L; Voudouragkaki, IC | 1 |
| Nuzzi, R; Rolle, T; Spinetta, R | 1 |
| Kim, YY; Na, KH; Park, JH; Yoo, C | 1 |
| Brown, GC; Brown, MM | 1 |
| Bourne, RRA; Kaarniranta, K; Lorenz, K; Ropo, A; Traverso, CE; Vuorinen, J | 1 |
| Akaishi, T; Fuwa, M; Kato, M; Mieda, M; Shimazaki, A; Taniguchi, T; Yamashita, N | 1 |
| Jin, SW; Joh, HJ | 1 |
| Holló, G; Kóthy, P; Oddone, F; Tanga, L | 1 |
| Arfaee, F; Asghari, A; Khaksar, E; Shokoohimand, A | 1 |
| Ansari, E; Ayan, F; King, AJ; Kinsella, M; Ng, E; Nita, A; Pavicic-Astalos, J | 1 |
| Ansari, E; Chappiti, S; Pavicic-Astalos, J; Pinto-Bonilla, JC; Riva, I; Sacchi, M; Saénz-Francés, F | 1 |
| Fassari, C; Holló, G; Kirwan, J; Lopez-Lopez, F; Oddone, F; Zimina, M | 2 |
| Oddone, F | 1 |
| Paul, C | 1 |
6 review(s) available for timolol and tafluprost
| Article | Year |
|---|---|
Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma.
Topics: Antihypertensive Agents; Drug Combinations; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Glaucoma; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Prostaglandins F; Timolol | 2014 |
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2014 |
Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.
Topics: Adrenergic beta-Antagonists; Amides; Cloprostenol; Double-Blind Method; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Preservatives, Pharmaceutical; Prostaglandins F; Randomized Controlled Trials as Topic; Timolol | 2014 |
Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma.
Topics: Antihypertensive Agents; Conjunctival Diseases; Drug Combinations; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Medication Adherence; Prostaglandins F; Timolol | 2015 |
Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Topics: Adrenergic beta-Antagonists; Drug Combinations; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F; Timolol | 2015 |
Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma.
Topics: Antihypertensive Agents; Disease Management; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Preservatives, Pharmaceutical; Prostaglandins F; Quality of Life; Timolol | 2016 |
8 trial(s) available for timolol and tafluprost
| Article | Year |
|---|---|
Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F; Timolol; Tonometry, Ocular; Treatment Outcome; Visual Acuity | 2012 |
Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F; Timolol; Young Adult | 2014 |
Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma.
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins F; Timolol; Treatment Outcome | 2015 |
A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
Topics: Adult; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prostaglandins F; Timolol; Tonometry, Ocular; Treatment Outcome | 2014 |
Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies.
Topics: Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prostaglandins F; Timolol; Young Adult | 2016 |
Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial.
Topics: Antihypertensive Agents; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; India; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prostaglandins F; Prostaglandins, Synthetic; Timolol | 2016 |
24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins F; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2017 |
Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intention to Treat Analysis; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F; Quality of Life; Timolol | 2019 |
17 other study(ies) available for timolol and tafluprost
| Article | Year |
|---|---|
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Hypertension; Miotics; Mydriasis; Ocular Hypertension; Pilocarpine; Prostaglandins F; Quinoxalines; Sulfonamides; Syndrome; Thiophenes; Timolol | 2013 |
Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models.
Topics: Administration, Ophthalmic; Animals; Antihypertensive Agents; Aqueous Humor; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Female; Glaucoma; Intraocular Pressure; Macaca fascicularis; Male; Ocular Hypertension; Prostaglandins F; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Timolol | 2015 |
Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops.
Topics: Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F; Retrospective Studies; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2015 |
Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
Topics: Animals; Antihypertensive Agents; Area Under Curve; Cell Line; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Metabolic Clearance Rate; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Time Factors; Timolol; Treatment Outcome | 2016 |
Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study.
Topics: Aged; Antihypertensive Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Microscopy, Confocal; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F; Tears; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2017 |
Eye Drop Dispenser Type and Medication Possession Ratio in Patients With Glaucoma: Single-Use Containers Versus Multiple-Use Bottles.
Topics: Administration, Ophthalmic; Aged; Antihypertensive Agents; Drug Combinations; Drug Packaging; Drug Utilization; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 2018 |
Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
Topics: Bimatoprost; Cost-Benefit Analysis; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Patient Preference; Prostaglandins F; Timolol; Travoprost; Visual Acuity | 2019 |
Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol.
Topics: Animals; Antihypertensive Agents; Carteolol; Cell Line; Drug Combinations; Epithelium, Corneal; Humans; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Prostaglandins F; Timolol | 2019 |
Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F; Retrospective Studies; Sulfonamides; Thiazines; Time Factors; Timolol; Treatment Outcome | 2019 |
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins F; Prostaglandins, Synthetic; Timolol; Tonometry, Ocular | 2020 |
Effects of topical administration of tafluprost and combination of tafluprost and timolol or tafluprost and betaxolol on Schirmer tear test, intraocular pressure, and pupil size in clinically healthy dogs.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Betaxolol; Dogs; Intraocular Pressure; Male; Prostaglandins F; Pupil; Timolol | 2020 |
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study.
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ireland; Ocular Hypertension; Prospective Studies; Prostaglandins F; Timolol; United Kingdom | 2021 |
Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes.
Topics: Aged; Antihypertensive Agents; Glaucoma, Open-Angle; Humans; Middle Aged; Ocular Hypertension; Prostaglandins F; Timolol | 2022 |
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Topics: Adult; Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins A; Prostaglandins F; Timolol; Travoprost | 2022 |
A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Drug Combinations; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins A; Prostaglandins F; Timolol; Treatment Outcome | 2022 |
Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability.
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Preservatives, Pharmaceutical; Timolol | 2022 |
Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure.
Topics: Antihypertensive Agents; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Prostaglandins F; Retrospective Studies; Timolol; Treatment Outcome | 2023 |